임상시험 트래커
추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov
기업
21건 표시
- 1상모집 중단 (진행 중)· Healthy AdultsA Study to Compare the Amount of Two Forms of Tafamidis in the Blood of Healthy Adults Under Fasting Conditions
리드: 화이자
- 1상모집 중단 (진행 중)· Healthy ParticipantA Study to Learn if a Medicine Called Itraconazole Changes How the Body Processes the Study Medicine PF-08642534 in Healthy Adults.
리드: 화이자
- 1상모집 중단 (진행 중)· Coronavirus Disease 2019A Study of How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir
리드: 화이자
- 1상모집 중단 (진행 중)· Healthy Adult ParticipantsA Study to Learn if Itraconazole Changes How the Body Processes PF-07248144 (Study Medicine)
리드: 화이자
- 1상모집 중단 (진행 중)· Streptococcus PneumoniaeA Study to Learn About How a New Pneumococcal Vaccine Works in Adults
리드: 화이자
- 1상모집 중단 (진행 중)· Pneumococcal DiseaseA Study to Understand the Safety of the 20vPnC Vaccine in Healthy Chinese Adults, Children, and Infant
리드: 화이자
- 1상모집 중단 (진행 중)· Carcinoma, Pancreatic DuctalA Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.
리드: 화이자
- 1상모집 중단 (진행 중)· Breast NeoplasmsA Study to Learn About the Vepdegestrant (ARV-471, PF-07850327) in People With ER+/HER2- Locally Advanced or Metastatic Breast Cancer (BC)
리드: 화이자
- 1상모집 중단 (진행 중)· B-cell Acute Lymphoblastic LeukemiaPhase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL
협력: 화이자
- 1상모집 중단 (진행 중)· Metastatic HER2+ Advanced Breast CancerSafety and Pharmacokinetics of Tucatinib (MK-7119) in Chinese Participants With Cancer (MK-7119-002)
리드: 화이자
- 1상모집 중단 (진행 중)· Breast CancerA Phase 1 Study of Oral OP-1250 in Combination With Palbociclib in HR+/HER2- Breast Cancer Patients
협력: 화이자
- 1상모집 중단 (진행 중)· Head and Neck Squamous Cell CarcinomaAvelumab, Cetuximab, and Palbociclib in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
협력: 화이자
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.